METROPOLITAN LIFE INSURANCE CO/NY - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$68,340
-7.8%
5,846
+6.0%
0.00%0.0%
Q2 2023$74,095
-18.9%
5,5130.0%0.00%
-20.0%
Q1 2023$91,406
-21.9%
5,513
-12.4%
0.01%0.0%
Q4 2022$117,068
+45.0%
6,2940.0%0.01%
+25.0%
Q3 2022$80,752
+83.0%
6,2940.0%0.00%
+100.0%
Q2 2022$44,121
-15.4%
6,2940.0%0.00%0.0%
Q1 2022$52,177
-67.3%
6,294
-73.3%
0.00%0.0%
Q4 2021$159,610
+14.0%
23,576
-10.7%
0.00%0.0%
Q3 2021$139,957
+9.2%
26,407
+18.4%
0.00%0.0%
Q2 2021$128,214
-8.3%
22,298
-26.5%
0.00%0.0%
Q1 2021$139,766
+52.0%
30,318
+10.1%
0.00%
+100.0%
Q4 2020$91,937
+10.7%
27,526
-1.6%
0.00%0.0%
Q3 2020$83,053
-42.2%
27,964
-10.0%
0.00%
-66.7%
Q2 2020$143,627
+85.3%
31,088
+54.4%
0.00%
+50.0%
Q1 2020$77,497
+28.8%
20,129
+25.4%
0.00%
+100.0%
Q4 2019$60,188
-68.3%
16,050
-55.1%
0.00%
-66.7%
Q3 2019$189,902
+74.9%
35,763
+26.5%
0.00%
+50.0%
Q2 2019$108,599
-24.7%
28,2810.0%0.00%
-33.3%
Q1 2019$144,233
+175.6%
28,281
+3.8%
0.00%
+200.0%
Q4 2018$52,326
-49.2%
27,2530.0%0.00%
-50.0%
Q3 2018$103,016
-99.9%
27,2530.0%0.00%
+100.0%
Q2 2018$85,030,000
+74.7%
27,253
+33.8%
0.00%0.0%
Q1 2018$48,680,000
+55854.0%
20,368
-8.3%
0.00%0.0%
Q4 2017$87,000
-36.0%
22,204
-60.1%
0.00%0.0%
Q4 2015$136,000
-4.2%
55,663
+17.3%
0.00%0.0%
Q3 2015$142,000
-39.6%
47,445
-16.6%
0.00%
-50.0%
Q2 2015$235,00056,8710.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders